Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
1.280
-0.120 (-8.57%)
At close: Feb 21, 2025, 4:00 PM
1.281
0.00 (0.04%)
After-hours: Feb 21, 2025, 7:50 PM EST
MBRX's stock price has decreased by -82.93% in the past year and price targets may not have had time to catch up.
Moleculin Biotech Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$24.00
Upside
+1,775.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $20 → $8 | Strong Buy | Maintains | $20 → $8 | +525.00% | Nov 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +3,025.00% | Apr 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $20 | Strong Buy | Maintains | $45 → $20 | +1,462.50% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +3,415.63% | Dec 14, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $240 | Strong Buy | Maintains | $240 | +18,650.00% | Apr 18, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $75 | Buy | Reiterates | $75 | +5,759.38% | Mar 24, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $30 → $210 | Buy | Initiates | $30 → $210 | +16,306.25% | Jul 18, 2022 |